First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma-Reference-Cited by-同舟云学术

First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

Published:2014-11-25 Issue:3 Volume:21 Page:553-560
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Rodon Jordi,Carducci Michael A.,Sepulveda-Sánchez Juan M,Azaro Analia,Calvo Emiliano,Seoane Joan,Braña Irene,Sicart Elisabet,Gueorguieva Ivelina,Cleverly Ann L.,Pillay N. Sokalingum,Desaiah Durisala,Estrem Shawn T.,Paz-Ares Luis,Holdhoff Matthias,Blakeley Jaishri,Lahn Michael M.,Baselga Jose

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma;Neuro-Oncology;2024-07-10

2. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta;Biomedicine & Pharmacotherapy;2024-06

3. Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines;Advanced Drug Delivery Reviews;2024-06

4. Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy;The FASEB Journal;2024-05-13

5. Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy;Journal of Cancer Metastasis and Treatment;2024-03-25